ReviewFrontiers in oncology2026
Research progress and narrative review of totally implantable venous access ports.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Totally Implantable Venous Access Ports (TIVAP) are specialized devices designed for long-term venous therapy, widely used in oncology and other groups requiring prolonged intravenous access. Since their introduction into routine clinical practice in China, they have significantly enhanced the safety and comfort of vascular access management. However, substantial challenges remain in TIVAP utilization as China lacks a unified regulatory framework and standardized full-lifecycle management protocols. Significant disparities also exist among medical institutions in terms of surgical techniques, complication management, and surveillance, leading to inconsistent outcomes and patient satisfaction. This narrative review presents a review of TIVAP clinical applications and maintenance, incorporating the latest evidence-based strategies for implantation and complication mitigation. The objective is to provide a comprehensive reference for optimizing clinical decision-making, minimizing adverse events, and improving patient quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.